Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?
From Yahoo Finance: 2025-03-28 19:06:00
- Market index and blue-chip companies declined, NASDAQ Composite down 1.6% due to Trump’s tariff update.
- Insider trading attracts attention during market uncertainty, not always lack of faith. Executives use pre-established plans for transparency.
- Insider Monkey’s list ranks 20 most expensive stocks insiders are selling in March based on average price per share.
- Vertex Pharmaceuticals (VRTX) stands as one of the most expensive stocks insiders are dumping in March.
- Vertex focuses on CF therapies, reported $11.02 billion product revenue for 2024, projects $11.75-$12 billion for 2025.
- UK approves ALYFTREK for CF treatment, insiders sold $10.09 million worth of shares at $497.58 each.
- Analysts rate VRTX as "Moderate Buy" with target price of $506.70 per share.
- VRTX ranks 9th on list of expensive stocks insiders are selling in March, AI stocks may offer higher returns.
Read more at Yahoo Finance: Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?